Reminder - Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2005 Financial Results

congenital defect

Russell W. Neurocrine will also host a live conference call and Webcast to discuss
its second quarter financial results and provide a Company update Wednesday
afternoon, August 3, 2005 at 4:30 PM Eastern Daylight Time (EDT) / 1:30 PM
Pacific Daylight Time (PDT). news releases are available through the Company's
website via the Internet at http://www.

diagnosis defect

PRESS RELEASE OR-Live.com Presents Advanced Fetal Care Center at Children 's Hospital Boston to Webcast a Featured Panel on Fetal Cardiac Interventions

(Click here for details)
The panel will offer up-to-date information on the latest treatments and
interventions for patients with complex cardiac fetal anomalies, as well as
expert discussions on diagnosis and state-of-the-art technologies from some
of the world's leading practitioners in fetal medicine. Company Will Also Present Update

SAN DIEGO, Neurocrine Biosciences , Inc.

fetal hereditary

Children's Hospital Boston, the pioneer in fetal cardiac intervention,
has performed more than 50 procedures to date. We welcome a wide range of maternal, prenatal
and pediatric health care professionals who provide care to these families
to this important conference.
If you are unable to attend the Webcast and would like further information
on this announcement please contact Claudia Jones -Woodworth or Elizabeth
Foster in the Investor Relations Department at Neurocrine Biosciences at
(858) 617-7600.

ocularist cardiac

The center is the
only one of its kind in New England and is a national leader in
comprehensive fetal care. The call can also be accessed via the Webcast through
the Company's website at http://www.

Anomalous conditions present at birth as a result of either hereditary or environmental influences during prenatal development, often referred to as birth defects.

ucsf newborn

In
addition to 325 pediatric and adolescent inpatient beds and comprehensive
outpatient programs, Children's houses the world 's largest research
enterprise based at a pediatric medical center, where its discoveries have
benefited both children and adults for 136 years.
(Nasdaq: NBIX) announced today that the Company will report second quarter
2005 financial results after the Nasdaq market closes Wednesday, August 3,
2005 .com

congenital goldenhar

newborn genetic

Jennings.

genetic defects

hereditary ucsf

"We believe that the sooner an anomaly can be correctly diagnosed, the
greater a child's chances of experiencing normal development and health,"
said AFCC Director Dr.

briefly cardiac

com.

goldenhar hereditary

ocularist defect

neurocrine.

referred defect

anomalies ocularist

A VNR is available at
http://www.) or 785-832-1508 (International) and using the
Conference ID# NBIX. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity.

genetic neurological

ucsf defects

Children's Hospital Boston is the nation 's leading pediatric medical
center, the largest provider of health care to Massachusetts' children , and
the primary pediatric teaching hospital of Harvard Medical School.com/rams/chh-1357-mkw-q.

Neurocrine Biosciences, Inc.

referred urological

prenatal defect

EDT.neurocrine.

cardiovascular urological

fetal prenatal

"

The Advanced Fetal Care Center (AFCC ) at Children's Hospital Boston serves
families facing complex birth defects and other critical challenges to the
health of their unborn and newborn infants.
Neurocrine Biosciences, Inc.

cardiovascular congenital

Visit http: //www.or-live.ram

is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.

newborn merck

Participants may access the live Conference Call
by dialing 1 -800-540-0559 (U. A replay of the Conference Call will be available
approximately one hour after the conclusion of the call by dialing
1-888-562-2815 (US) or 402-220-7352 (International) and will be archived until
Wednesday, August 17, 2005.

musculoskeletal anomalies

M. The center holds a place of
distinction as a pioneer in fetal cardiac intervention.

prenatal anomalous

The Advanced Fetal Care Center at Children's
Hospital Boston will webcast live a featured panel on fetal cardiac
interventions to medical audiences around the world at The Conference
Center at Harvard Medical School on Friday, April 29 from 2:00 to 3:00 P . "Our mission is to share
breakthrough treatments in fetal and pediatric medicine and surgery with a
broad, multi-disciplinary group in order to significantly improve the
quality of life for this special group of newborns through their first
years and early childhood.com/childrenshospitalboston /1357 now to view a
program preview.or-live.